Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn. by Rui Gong, Yanping Wang, Tianlei Ying, Dimiter S Dimitrov

Get full text

Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy by Seungmin Shin, Du-San Baek, John W. Mellors, Dimiter S. Dimitrov, Wei Li

Get full text

Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model. by Xiaodong Xiao, Zhongyu Zhu, Jennifer L Dankmeyer, Michael M Wormald, Randy L Fast, Patricia L Worsham, Christopher K Cote, Kei Amemiya, Dimiter S Dimitrov

Get full text

GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies by Paul M Sondel, Amy K Erbe, Daniel Martinez, Samantha N Buongervino, Kristopher R Bosse, Guillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, Doncho V Zhelev, Shakhnozakhon Sadirova, Anna M Giudice, Laura Garcia-Gerique, Dimiter S Dimitrov

Get full text

Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer by Xiaojie Chu, Seungmin Shin, Du-San Baek, Liyong Zhang, Alex Conard, Megan Shi, Ye-Jin Kim, Cynthia Adams, Maggie Hines, Xianglei Liu, Chuan Chen, Zehua Sun, Dontcho V. Jelev, John W. Mellors, Dimiter S. Dimitrov, Wei Li

Get full text